Men with Low Cholesterol Levels at Reduced Prostate Cancer Risk
November 4, 2009
Boston (DbTechNo) - Men who eat a healthy diet resulting in low levels of bad cholesterol may actually reduce their own risk of being diagnosed with aggressive prostate cancer.
In a study published today in Cancer Epidemiology Biomarkers & Prevention, researchers state that men who have cholesterol levels below 200, are far less likely to be diagnosed with prostate cancer than those men whose levels are above 200.
The researchers analyzed 5,586 health records of men who took part in a cancer study carried out in the 90’s.
The researchers noted that although prostate cancer was diagnosed in a relatively equal number of participants despite their cholesterol levels, only those with levels over 200 were at greater risk of developing a severely dangerous form of the disease.
Generally prostate cancer is one of the slower progressing types of cancer, and in some cases a patient can end up dying from an unrelated cause altogether.
Prostate cancer is the most common cancer to be diagnosed in men, and an estimated 192,000 new cases will be diagnosed in America this year.
Comments
2 Responses to “Men with Low Cholesterol Levels at Reduced Prostate Cancer Risk”
All comments are moderated.
If your comment is approved, it will be posted within 24 hours
Breaking News
Lil Wayne to be Sentenced in Gun Possession CaseBoston (DbTechNo) - Rapper Lil Wayne will be sentenced today after pleading guilty to gun possession charges. The charges...
Autism Risk Increases in Children with Older MothersBoston (DbTechNo) - When it comes to the risk of a child developing autism a lot depends on the age of his or her mother...
Antidepressant Interfeers With Breast Cancer Drug tamoxifenBoston (DbTechNo) - The antidepressant drug paxil has been shown to interfeer with a leading breast cancer drug called tamoxifen. According...
Prostaglandins are infinitesimal, ephemeral and powerful signaling molecules that self-regulate the chemistry of every cell in the body, including cells regulating mood, and those regulating immune function. When produced within normal limits, prostaglandins regulate physiology; when produced excessively, physiology becomes pathology. When brain cells produce excessive concentrations of prostaglandins, they depress mood and immunity. In 1973, David Horrobin showed that antidepressants inhibit prostaglandins, and in 1977, that prostaglandins regulate nucleic acids (DNA and RNA).1,2 Others subsequently showed that prostaglandins regulate the synthesis, inhibition, and expression of genes, and the growth and replication of cells, with cancer the accelerated replication of abnormal cells.1,2 Excessive synthesis of prostaglandins induces cancer, with genes determining the variations. In 1998 Brenda Penninx published a key study showing that age 70 chronically depressed people have an increased risk of 88% of developing cancer, and of 50% of dying of it.
More than fifty studies have shown that antidepressants kill cancer cells, inhibit their proliferation, convert multidrug resistant cells to sensitive, protect nonmalignant cells from damage by radiation and chemotherapy toxicity, and target the mitochondria of cancer cells while sparing those of healthy ones.1,2 Antidepressants have therapeutic potential in many cancers that are often treatment resistant, such as gliomas, cancers of the lung, kidney, liver, and uterus, inflammatory breast cancer, and multiple myelomas.2 Antidepressants are capable of arresting cancer in advanced stages, and even reversing it. That antidepressants are effective for a multitude of malignancies, decries the myth that cancer is a hundred diseases, when it is one disease with a hundred variations. Antidepressants alleviate cancer pain, alone or combined with narcotics, remit nausea and vomiting, promote sleep, relieve anxiety and depression, and combat fatigue. Other inhibitors of prostaglandins, such as non-steroidal, anti-inflammatory drugs as aspirin, indomethacin, ibuprofen, and piroxicam, and COX-2 inhibitors, also have potential value in defeating cancer.
Sincerely,
Julian Lieb, M.D
1.Lieb, J.”The multifaceted value of antidepressants in cancer therapeutics.” Eur J Cancer. Editorial Comment. (2008) 172-174
2.Lieb, J.”Defeating cancer with antidepressants.” ecancermedicalscience DOI.10.3332/eCMS.2008.88
This study bears out the assertion that an Eastern diet, high in whole grains, and vegitatrian or very low on animal protein is a real key with cancer. Read The China Study by T. Colin Campbell, and/or Roger Mason’s Zen Macrobiotics for Americans.